운영 비용 변화 날짜
Acadia Pharmaceuticals USD 270.57M 450K 2026-09
Akebia Therapeutics USD 63.08M 8.26M 2025-12
ALKERMES USD 1.86B 56.17M 2026-09
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
Amarin USD 51.48M 113K 2025-12
ANI Pharmaceuticals USD 637.11M 39.9M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Coherus Biosciences USD 51.83M 2.48M 2025-12
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Exelixis USD 390.27M 10M 2026-09
Glaxosmithkline GBP 6.76B 1.42B 2026-09
Heron Therapeutics USD 40.55M 1.46M 2025-12
Ionis Pharmaceuticals USD 373M 2.76M 2026-09
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Lonza CHF 2.9B 184M 2025-06
Merck USD 10.75B 5.02B 2026-09
Moderna USD 1.18B 223M 2026-09
Myriad Genetics USD 212.8M 16.2M 2025-12
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Neurocrine Biosciences USD 779.7M 40.6M 2026-09
Pacira USD 1.18B 995.96M 2026-09
Pfizer USD 89B 3.81B 2026-09
PTC Therapeutics USD 211.54M 15.12M 2026-06
Sanofi EUR 10.51B 598M 2026-09
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
United Therapeutics USD 6.28B 124.3M 2026-09
Vanda Pharmaceuticals USD -1.14B 1.6B 2025-12